Related Experiment Video
Updated: Sep 28, 2026
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity
Jason R Baker1, Soisungwan Satarug, Robert J Edwards
1National Research Center for Environmental Toxicology, University of Queensland, 39 Kessels Road, Coopers Plains, Qld. 4108, Brisbane, Australia. s374705@student.uq.edu.au
Abstract:
This paper investigates the possible link between non-workplace cadmium (Cd) exposure, cytochrome P450 expression and hypertension. We present results of our investigation into the relationships between liver and kidney Cd burdens and the abundance of the CYP isoform 4A11. Our data show associations between non-workplace Cd exposure and changes in the abundance of hepatic and renal cortical CYP4A11. In liver the levels of immunochemically detectable CYP4A11 were positively correlated with tissue Cd content while in contrast CYP4A11 abundance was inversely correlated with kidney Cd burden. These differences are most likely related to the different Cd burden of the tissues. These observations suggest the potential for involvement of Cd as a mediator of CYP4A11 expression in kidney cortex and indicate that elevations in kidney Cd content may be involved in hypertension via alteration of the expression of this particular isoform. Potential mechanisms by which Cd may alter CYP4A11 expression are discussed briefly.
Insights
Non-workplace cadmium exposure impacts cytochrome P450 (CYP4A11) expression in the liver and kidneys. Kidney cadmium may alter CYP4A11, potentially contributing to hypertension.
Area of Science:
- Environmental Health
- Toxicology
- Biochemistry
Background:
- Non-workplace exposure to environmental toxins like cadmium (Cd) is a growing concern.
- Cadmium's role in chronic diseases, including hypertension, is under investigation.
- Cytochrome P450 enzymes, such as CYP4A11, are crucial in metabolic processes and can be influenced by environmental factors.
Purpose of the Study:
- To investigate the relationship between non-workplace cadmium exposure and cytochrome P450 (specifically CYP4A11) expression.
- To explore the potential link between cadmium burdens in the liver and kidneys and CYP4A11 abundance.
- To determine if cadmium-induced alterations in CYP4A11 expression are associated with hypertension.
Main Methods:
- Quantified cadmium burdens in liver and kidney tissues.
- Measured the abundance of CYP4A11 using immunochemical methods.
- Analyzed correlations between tissue cadmium levels and CYP4A11 expression.
- Investigated associations between non-workplace cadmium exposure and these molecular changes.
Main Results:
- Non-workplace cadmium exposure was associated with altered CYP4A11 abundance in both hepatic and renal tissues.
- Liver CYP4A11 levels showed a positive correlation with cadmium burden.
- Kidney CYP4A11 abundance demonstrated an inverse correlation with cadmium burden.
Conclusions:
- Cadmium exposure may mediate CYP4A11 expression in the kidney cortex.
- Elevated kidney cadmium levels might contribute to hypertension through altered CYP4A11 expression.
- The differential effects of cadmium on CYP4A11 in liver versus kidney warrant further mechanistic investigation.